Bullboard - Stock Discussion Forum Acorda Therapeutics Inc ACORQ

Healthcare Biotechnology

Acorda Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. The Company markets Inbrija (levodopa inhalation powder), which is approved in the United States for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson’s disease treated with carbidopa... see more

Add To Watchlist

OTCPK:ACORQ - Post Discussion

Acorda Therapeutics Inc > ACOR...Don't let the door hit ya in the butt when ur leaving

View:

Post by Iseneschal on Apr 15, 2024 5:17pm

ACOR...Don't let the door hit ya in the butt when ur leaving

Acorda Therapeutics Announces Delisting from Nasdaq

2024-04-15 14:03 ET - News Release

Company Website: https://www.acorda.com/
PEARL RIVER, N.Y. -- (Business Wire)

Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of Chapter 11 proceedings and Nasdaq Listing Rule 5450(b)(1)(A) for failure to maintain stockholders’ equity of at least $10 million. Trading in the Company’s common stock on the Nasdaq exchange was suspended on April 12, 2024. The Company’s common stock is quoted on the OTC Pink^® Open Market platform operated by OTC Markets Group Inc. since April 12, 2024 under the “ACORQ” ticker symbol.